TNF-α Reporter HEK 293 Cells

NF-κB-SEAP reporter cells

ABOUT

TNF-α responsive NF-κB/AP1-SEAP reporter assay

HEK-Blue™ TNF-α cells are designed to monitor human TNF-α-induced NF-κB/AP-1 stimulation or inhibition. This colorimetric bioassay can be used for screening activatory molecules, such as engineered cytokines, or inhibitory molecules, such as neutralizing antibodies.

HEK-Blue™ TNF-α cells respond specifically to recombinant human TNF-α . The reliable and consistent performance of HEK-Blue™ TNF-α cells makes them suitable for release assays of therapeutic molecules that inhibit TNF-α signaling, such as Adalimumab, a therapeutic monoclonal antibody targeting TNF-α (see figures).
 

Key features

  • Readily assessable NF-κB/AP-1-SEAP reporter activity
  • Convenient readout using QUANTI-Blue™ Solution
  • High sensitivity to human (h) and mouse (m) TNF-α
  • Stability guaranteed for 20 passages

Applications

  • Therapeutic development
  • Drug screening
  • Release assay

 

Tumor necrosis factor alpha (TNF-α) is a multi-functional pro-inflammatory cytokine involved in regulating a wide spectrum of biological processes, such as cell proliferation, differentiation, and apoptosis.

more detailsMore details

Disclaimer:  These cells are for internal research use only and are covered by a Limited Use License (See Terms and Conditions). Additional rights may be available.

SPECIFICATIONS

Specifications

Target

TNF-α

Tested applications

Detection and quantification of TNF-α activity

Cell type
Epithelial
Growth properties
Adherent
Tissue origin
Human embryonic kidney cells
Reporter gene
SEAP
Detection method
Colorimetric
Detection range

hTNF-α EC50: 0.01 ng/ml (in medium) or 0.7 ng/ml (in water)
mTNF-α EC50: 0.1 ng/ml (in medium) or 3 ng/ml (in water)

Antibiotic resistance
Puromycin
Zeocin®
Growth medium

Complete DMEM (see TDS)

Mycoplasma-free

Verified using Plasmotest™

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    HEK-Blue™ TNF-α Cells
  • Cat code: 
    hkb-tnfdmyd
  • Quantity: 
    3-7 x 10^6 cells
Includes:
  • 1 ml of Puromycin (10 mg/ml)
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Normocin® (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

Shipping & Storage

  • Shipping method:  Dry ice
  • Storage:

    • Liquid nitrogen vapor
    Stability: 20 passages

    Caution:

    • Upon receipt, store immediately in liquid nitrogen vapor. Do not store cell vials at -80°C.

Details

Cell line description

HEK-Blue™ TNF-α cells were generated by stable transfection with the genes encoding for the human TNF-α receptor (TNFR1 and TNFR2 chains), as well as an NF-κB/AP-1-inducible SEAP secreted embryonic alkaline phosphatase (SEAP) reporter. The binding of TNF-α to its receptor triggers a signaling cascade leading to NF-κB/AP1 activation and the subsequent production of SEAP. This can be readily assessed in the supernatant using QUANTI-Blue™ Solution, a SEAP detection reagent.

HEK-Blue™ TNF-α cells respond to recombinant human TNF-α, as well as recombinant mouse TNF-α (see figures). Of note, these cells are not responsive to human IL-1β. They can also be used for screening and release assay of molecules that inhibit TNF-α signaling, such as adalimumab, a monoclonal antibody targeting TNF-α.

 

TNF-α Background

Tumor necrosis factor-alpha (TNF-α) is a pleiotropic cytokine involved in necrotic and apoptotic cell death, cellular differentiation, inflammation, and regulation of immune cell activity [1]. Notably, deregulated TNF-α production has been implicated in a variety of conditions, including autoimmune and inflammatory diseases [1].

TNF-α is mainly produced by activated monocytes, macrophages, and T cells. It is first synthesized as a membrane-bound molecule that forms a compact homotrimer through non-covalent interactions. The trimeric membrane-bound form is cleaved by tumor necrosis factor-alpha converting enzyme (TACE) releasing the soluble trimer [2]. Both the membrane-bound and soluble TNF-α bind homotrimeric transmembrane receptors, TNFR1 or TNFR2, triggering signaling pathways that involve TRADD, TRAF2, and RIP, and leading to the activation of NF-κB and MAPK pathways.

 

1. Steeland S. et al., 2018. A new venue of TNF targeting. Int. J. Mol. Sci. 19:1442.
2. Brenner D. et al., 2015. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 15(6):362-74.

DOCUMENTS

Documents

HEK-Blue™ TNF-α Cells

Technical Data Sheet

Validation Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?